Literature DB >> 20817872

Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression.

Javier Ochoa-Repáraz1, Daniel W Mielcarz, Lauren E Ditrio, Ashley R Burroughs, Sakhina Begum-Haque, Suryasarathi Dasgupta, Dennis L Kasper, Lloyd H Kasper.   

Abstract

The importance of gut commensal bacteria in maintaining immune homeostasis is increasingly understood. We recently described that alteration of the gut microflora can affect a population of Foxp3(+)T(reg) cells that regulate demyelination in experimental autoimmune encephalomyelitis (EAE), the experimental model of human multiple sclerosis. We now extend our previous observations on the role of commensal bacteria in CNS demyelination, and we demonstrate that Bacteroides fragilis producing a bacterial capsular polysaccharide Ag can protect against EAE. Recolonization with wild type B. fragilis maintained resistance to EAE, whereas reconstitution with polysaccharide A-deficient B. fragilis restored EAE susceptibility. Enhanced numbers of Foxp3(+)T(reg) cells in the cervical lymph nodes were observed after intestinal recolonization with either strain of B. fragilis. Ex vivo, CD4(+)T cells obtained from mice reconstituted with wild type B. fragilis had significantly enhanced rates of conversion into IL-10-producing Foxp3(+)T(reg) cells and offered greater protection against disease. Our results suggest an important role for commensal bacterial Ags, in particular B. fragilis expressing polysaccharide A, in protecting against CNS demyelination in EAE and perhaps human multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817872     DOI: 10.4049/jimmunol.1001443

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  166 in total

Review 1.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA.

Authors:  Neeraj K Surana; Dennis L Kasper
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 2.  Control of antiviral immunity by pattern recognition and the microbiome.

Authors:  Iris K Pang; Akiko Iwasaki
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

Review 3.  Influence of dietary components on regulatory T cells.

Authors:  Shohreh Issazadeh-Navikas; Roman Teimer; Robert Bockermann
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 4.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

Review 6.  Microbiota-immune system interaction: an uneasy alliance.

Authors:  Nita H Salzman
Journal:  Curr Opin Microbiol       Date:  2010-10-21       Impact factor: 7.934

Review 7.  Shifting the balance: antibiotic effects on host-microbiota mutualism.

Authors:  Benjamin P Willing; Shannon L Russell; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2011-02-28       Impact factor: 60.633

Review 8.  Healthy Human Gastrointestinal Microbiome: Composition and Function After a Decade of Exploration.

Authors:  Wenly Ruan; Melinda A Engevik; Jennifer K Spinler; James Versalovic
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

9.  Gut microbiota utilize immunoglobulin A for mucosal colonization.

Authors:  G P Donaldson; M S Ladinsky; K B Yu; J G Sanders; B B Yoo; W-C Chou; M E Conner; A M Earl; R Knight; P J Bjorkman; S K Mazmanian
Journal:  Science       Date:  2018-05-03       Impact factor: 47.728

Review 10.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.